6 crore Hospital Admissions Costing Rs 77,298 Cr Under AB PM-JAY Till Nov, 23: Govt To LS

NEW DELHI:  Approximately six crore hospital admissions entailing an expenditure of Rs 77,298 crore have been authorised under the Ayushman Bharat Pradhan Mantri Jan Arogya Yojana till November 30, Union health minister Mansukh Mandaviya told Lok Sabha on Friday. As of December 2, a total of 26,774 hospitals, including 11,733 private facilities, across the country have been empanelled to provide healthcare services to the scheme beneficiaries, he said, adding that 4.98 crore claims have been submitted between financial years 2020-21 and 2023-24 as of November 30.

The AB PM-JAY is the largest publicly funded health assurance scheme in the world which aims to provide health cover of rs 5 lakh per family yearly for secondary and tertiary care hospitalization to 12 crore families, the Union health minister said.

He said AB PM-JAY provides health cover to families which constitute the bottom 40 per cent of the population. The budget allocated for Ayushman Bharat PM-JAY for the financial year 2023-24 is rs 7,200 crore, he said.

“With respect to utilization, it may kindly be noted that as of November 30, 2023, approximately, six crore hospital admissions worth rs 77,298 crore have been authorised under the scheme,” he said.

The AB PM-JAY scheme is completely cashless and paperless and without the concept of reimbursement. Beneficiaries can avail treatment under defined packages.

The Empanelled Healthcare Providers are paid based on specified health benefit packages with standardised rates.

As per the latest health benefit packages (2022), a total of 1,949 procedures across 27 specialities are available for AB PM-JAY beneficiaries. Further, states and Union Territories have been given the flexibility to add state-specific packages over and above the national master.

Also, they have been provided flexibility to change the cost of the package as per local requirements. The scheme provides treatment corresponding to a total of 1,949 procedures under 27 different specialities, including diseases such as cancer, diabetes and heart ailments.

Leprosy as a package is not included under PM-JAY. However, 26 procedures related to skin diseases and 549 procedures related to cancer are covered under AB PM-JAY.

“Further, to ensure that AB PM-JAY beneficiaries are not denied care for treatments/procedures that do not feature in the health benefit packages, one unspecified package has been included in it to avail treatment for such procedures under the scheme.

“Approximately 34.92 lakh hospital admissions worth rs 6,537 crore and 1.68 lakh hospital admissions worth rs 254 crore have been authorized as of December 2, 2023, under Ayushman Bharat PM-JAY for cancer-related treatment and skin-related treatment respectively,” Mandaviya stated.

Related Posts

Gleneagles BGS Hospital honours donor families with India’s largest organ donation recognition wall

Gleneagles BGS Hospital, Kengeri, Bengaluru, part of the Fortis Healthcare Network, marked World Organ Donation Day with its annual commemorative event, ‘A Legacy That Lives On.’ The event brought together…

NCB Uncovers Pharmaceutical Fentanyl Diversion Racket in Rural Punjab; Over 18,000 NDPS Drug Units Seized

Punjab: The Narcotics Control Bureau (NCB) has uncovered an alleged pharmaceutical-drug diversion network operating through rural areas of Punjab. Investigators are tracing the movement of fentanyl and other drugs regulated…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Gleneagles BGS Hospital honours donor families with India’s largest organ donation recognition wall

Gleneagles BGS Hospital honours donor families with India’s largest organ donation recognition wall

NCB Uncovers Pharmaceutical Fentanyl Diversion Racket in Rural Punjab; Over 18,000 NDPS Drug Units Seized

NCB Uncovers Pharmaceutical Fentanyl Diversion Racket in Rural Punjab; Over 18,000 NDPS Drug Units Seized

Sun Pharma will Need HC Nod for Semaglutide Tablet Launch

Sun Pharma will Need HC Nod for Semaglutide Tablet Launch

Bombay HC tells Maharashtra FDA to be ‘judicious’ after Cadila challenges order to ban sale of some medicines

Bombay HC tells Maharashtra FDA to be ‘judicious’ after Cadila challenges order to ban sale of some medicines

‘Erring pharma companies’: Over 1,000 cough syrup manufacturers undergo intense audits

‘Erring pharma companies’: Over 1,000 cough syrup manufacturers undergo intense audits

Maharashtra FDA permanently cancels Pune-based pharma firm’s license over six contaminated medicines, GMP lapses

Maharashtra FDA permanently cancels Pune-based pharma firm’s license over six contaminated medicines, GMP lapses